Gimmicks...?

Valeant Pharmaceuticals (VRX) continues to be pushed down. If you thought it couldn't get any worse, it just did. 

The stock fell by nearly 10%  below $11. Since August 1st, 2015 shares of VRX are down nearly 95%, from around $260 per share.

Unfortunately, one lives by leverage and dies by leverage. In this case, VRX is drowning in leverage. VRX's most famous shareholder just told the world there are better places to put your money. 

Valeant grew quickly with a series of mergers and acquisitions and for a short period of time in 2015 was the most valuable company in Canada. Valeant was described as a platform company that grows by systematically acquiring other companies.

In 2015–2016 the company was involved in a controversy drug price hikes and the use of a specialty pharmacy for the distribution of its specialty drugs, dancing around US Laws.

What about other specialty pharmacies... Gimmicks?  Just a thought.